Citation: Ph. Maxwell et al., Insights into the role of the von Hippel-Lindau gene product - A key player in hypoxic regulation, EXP NEPHROL, 9(4), 2001, pp. 235-240
Authors:
Masson, N
Willam, C
Maxwell, PH
Pugh, CW
Ratcliffe, PJ
Citation: N. Masson et al., Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation, EMBO J, 20(18), 2001, pp. 5197-5206
Authors:
Epstein, ACR
Gleadle, JM
McNeill, LA
Hewitson, KS
O'Rourke, J
Mole, DR
Mukherji, M
Metzen, E
Wilson, MI
Dhanda, A
Tian, YM
Masson, N
Hamilton, DL
Jaakkola, P
Barstead, R
Hodgkin, J
Maxwell, PH
Pugh, CW
Schofield, CJ
Ratcliffe, PJ
Citation: Acr. Epstein et al., C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation, CELL, 107(1), 2001, pp. 43-54
Authors:
Jaakkola, P
Mole, DR
Tian, YM
Wilson, MI
Gielbert, J
Gaskell, SJ
von Kriegsheim, A
Hebestreit, HF
Mukherji, M
Schofield, CJ
Maxwell, PH
Pugh, CW
Ratcliffe, PJ
Citation: P. Jaakkola et al., Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O-2-regulated prolyl hydroxylation, SCIENCE, 292(5516), 2001, pp. 468-472
Authors:
Vaux, EC
Wood, SM
Cockman, ME
Nicholls, LG
Yeates, KM
Pugh, CW
Maxwell, PH
Ratcliffe, PJ
Citation: Ec. Vaux et al., Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor, J BIOL CHEM, 276(47), 2001, pp. 44323-44330
Citation: U. Modlich et al., Increasing endothelial cell specific expression by the use of heterologoushypoxic and cytokine-inducible enhancers, GENE THER, 7(10), 2000, pp. 896-902
Authors:
Wykoff, CC
Pugh, CW
Maxwell, PH
Harris, AL
Ratcliffe, PJ
Citation: Cc. Wykoff et al., Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling, ONCOGENE, 19(54), 2000, pp. 6297-6305
Authors:
Cockman, ME
Masson, N
Mole, DR
Jaakkola, P
Chang, GW
Clifford, SC
Maher, ER
Pugh, CW
Ratcliffe, PJ
Maxwell, PH
Citation: Me. Cockman et al., Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein, J BIOL CHEM, 275(33), 2000, pp. 25733-25741
Authors:
Talks, KL
Turley, H
Gatter, KC
Maxwell, PH
Pugh, CW
Ratcliffe, PJ
Harris, AL
Citation: Kl. Talks et al., The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages, AM J PATH, 157(2), 2000, pp. 411-421
Authors:
Maxwell, PH
Wiesener, MS
Chang, GW
Clifford, SC
Vaux, EC
Cockman, ME
Wykoff, CC
Pugh, CW
Maher, ER
Ratcliffe, PJ
Citation: Ph. Maxwell et al., The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, NATURE, 399(6733), 1999, pp. 271-275
Authors:
O'Rourke, JF
Tian, YM
Ratcliffe, PJ
Pugh, CW
Citation: Jf. O'Rourke et al., Oxygen-regulated and transactivating domains in endothelial PAS protein 1:Comparison with hypoxia-inducible factor-1 alpha, J BIOL CHEM, 274(4), 1999, pp. 2060-2071